Clinical Trials for Artios Pharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Artios Pharma

Clinical Trials (4)

NCT05898399
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients
PHASE1/PHASE2Active, not recruiting
220 participants
Started: Jun 30, 2023 · Completed: Dec 14, 2026
2 conditions1 sponsor7 locations
NCT05378204
Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.
NARecruiting
120 participants
Started: Jun 23, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors25 locations
NCT04991480
A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors
PHASE1Active, not recruiting
390 participants
Started: Sep 13, 2021 · Completed: Mar 31, 2026
3 conditions1 sponsor8 locations
NCT04657068
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
502 participants
Started: Dec 13, 2020 · Completed: Dec 31, 2026
9 conditions1 sponsor71 locations